chr17-63435225-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001915.4(CYB561):āc.424T>Cā(p.Phe142Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,613,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001915.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB561 | NM_001915.4 | c.424T>C | p.Phe142Leu | missense_variant | 5/6 | ENST00000360793.8 | NP_001906.3 | |
CYB561 | NM_001330421.2 | c.445T>C | p.Phe149Leu | missense_variant | 5/6 | NP_001317350.1 | ||
CYB561 | NM_001017916.2 | c.424T>C | p.Phe142Leu | missense_variant | 5/6 | NP_001017916.1 | ||
CYB561 | NM_001017917.2 | c.424T>C | p.Phe142Leu | missense_variant | 5/6 | NP_001017917.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000919 AC: 14AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000232 AC: 58AN: 249676Hom.: 0 AF XY: 0.000303 AC XY: 41AN XY: 135220
GnomAD4 exome AF: 0.000115 AC: 168AN: 1461276Hom.: 0 Cov.: 32 AF XY: 0.000173 AC XY: 126AN XY: 726924
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74528
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.424T>C (p.F142L) alteration is located in exon 5 (coding exon 4) of the CYB561 gene. This alteration results from a T to C substitution at nucleotide position 424, causing the phenylalanine (F) at amino acid position 142 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at